Skandinaviska Enskilda Banken AB (publ) - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 211 filers reported holding LEGEND BIOTECH CORP in Q4 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q2 2024$544,705
-11.7%
12,300
+11.8%
0.00%0.0%
Q1 2024$616,880
-6.1%
11,000
+0.9%
0.00%
-25.0%
Q4 2023$657,270
+127031.5%
10,900
+41.6%
0.00%
+33.3%
Q3 2023$517
-2.8%
7,7000.0%0.00%0.0%
Q2 2023$532
+43.0%
7,7000.0%0.00%0.0%
Q1 2023$372
-3.1%
7,7000.0%0.00%0.0%
Q4 2022$3847,7000.00%
Other shareholders
LEGEND BIOTECH CORP shareholders Q4 2023
NameSharesValueWeighting ↓
FengHe Fund Management Pte. Ltd. 372,989$10,824,0008.53%
Johnson & Johnson Innovation - JJDC, Inc. 1,629,173$47,279,0006.12%
Vivo Capital, LLC 2,755,007$79,950,0002.81%
Consonance Capital Management LP 896,608$26,020,0002.77%
Yong Rong (HK) Asset Management Ltd 198,312$5,756,0001.58%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,054,242$30,594,0001.28%
Hudson Bay Capital Management LP 2,167,274$62,894,0000.78%
Capital International, Inc./CA/ 1,916,845$55,627,0000.52%
Capital International Sarl 172,546$5,007,0000.48%
Novo Holdings A/S 254,176$7,376,0000.30%
View complete list of LEGEND BIOTECH CORP shareholders